| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191312 | Annals of Allergy, Asthma & Immunology | 2013 | 4 Pages |
Abstract
Emerging and ongoing research on clinical phenotypes and biomarkers of CVID may help identify and better target treatment for patients with CVID who will develop secondary complications. It is hoped that through this improved knowledge of outcomes, more appropriate treatment for patients can be targeted.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Mark MD,